FDA Inspection 869336 — Recipharm Stockholm AB
The FDA completed an inspection of Recipharm Stockholm AB on March 11, 2014 in Arsta. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 2 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 11, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Arsta (Sweden)
Citations
| ID | CFR | Description |
|---|---|---|
| 1395 | 21 CFR 211.103 | Actual vs. theoretical yields not determined |
| 2027 | 21 CFR 211.192 | Investigations of discrepancies, failures |